|Aktieselskab A/S Danish Public Limited stock based corporation|
|Founder||August Kongsted and Anton Antons|
|Headquarters||Ballerup, Copenhagen, Denmark|
|Gitte Aabo (CEO)|
|Products||Prescription drugs for dermatology, bone remodeling thrombosis and coagulation|
|Revenue||7.973 billion DKK (2014)|
|Total assets||31.627 billion DKK (2014)|
Number of employees
|Footnotes / references
Wholly owned by a foundation (nonprofit)
Leo Pharma A/S is a multinational Danish pharmaceutical company, founded in 1908, with a presence in about 100 countries. Its headquarters are in Ballerup, near Copenhagen The company is 100% integrated into a private foundation owned by the LEO Foundation. Leo Pharma develops and markets products for dermatology, bone remodeling thrombosis and coagulation. In 1945 it was the first producer of penicillin outside the USA and UK.
Formation & the 20th Century
In 1908, pharmacists August Kongsted and Anton Antons bought the LEO Pharmacy in Copenhagen, Denmark. With the purchase, they established 'Københavns Løveapoteks kemiske Fabrik', today known as LEO Pharma. LEO Pharma celebrated its centennial in 2008. Flags bearing the LEO logo were flying in every country where LEO products are available, more than a hundred flags in total. Today, LEO Pharma has an ever growing pipeline with over 4,800 specialists focussing on dermatology and thrombosis.
- 1912 – The company launched its own Aspirin headache tablet
- 1917 – The company exported Denmarks first drug, Digisolvin
- 1940 – The company launched its own Heparin product.
- 1958-08-13 - Patent filed for Bendrofluazide.
- 1962 – The company launched Fucidin to be used to treat staphylococcus infections
21st Century & onwards
|This pharmacology-related article is a stub. You can help Wikipedia by expanding it.|